Infertility is the inability of a person
to reproduce naturally. Female infertility is the inability of a woman
to become pregnant and carry pregnancy to full term. It is the most
common issue faced by couples trying to conceive. The most commonly
diagnosed causes of female infertility are ovulation problems, hormonal
imbalance, anatomical disorders of the reproductive system such as
damage caused to the fallopian tubes, uterus, or cervix; overuse of
alcohol or drugs, thyroid gland-associated issues, excessive weight, and
stress. A large number of men and women who are infertile due to
anatomical factors or chromosomal defects are finding favorable outcomes
through in vitro fertilization (IVF). Improper lifestyle changes have
also aggravated the problem of infertility.
Rise in infertility rate among men and
women in several developing and developed regions has led to increase in
demand for in vitro fertilization procedures. In several developed
countries, IVF is gaining prominence among fertile couples who are
suffering from genetic diseases and do not want to transfer these to
their offspring. Recent advancements in IVF devices and reagents also
augurs well for the market. Rise in medical tourism in some developing
countries is expected to present significant opportunities in the market
in the next few years.
The global IVF devices and consumables
market can be segmented based on product type, end-user, and region. In
terms of product type, the market can be categorized into equipment,
reagents, and others. The reagents segment is projected to account for
major IVF devices and consumables market share during the forecast
period owing to high usage of consumable products during the in vitro
fertilization process. Based on end-user, the global IVF devices and
consumables market can be classified into hospitals, gynecological
clinics, infertility care centers, and research & development
laboratories.
In terms of region, the global IVF
devices and consumables market can be segmented into North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa. North
America is expected to dominate the global IVF devices and consumables
market owing to high awareness, accurate diagnosis, high spending
capacity, and adoption of technologically advanced products. The IVF
devices and consumables market in Asia Pacific is anticipated to expand
at the highest CAGR during the forecast period, attributed to evolving
economy, rise in prevalence of hormonal disorders, increase in the
number of gynecologists, and availability of IVF facilities even in
rural areas of the region. Rise in awareness about infertility therapies
among the population in the developing regions such as Latin America
and Middle East & Africa are anticipated to drive the IVF devices
and consumables market.
Key players operating in the global IVF
devices and consumables market include Thermo Fisher Scientific, Inc.,
Cook Medical, Merck KGaA, Vitrolife AB, Ovascience, Inc.,
CooperSurgical, EMD Serono, Inc., Genea Ltd., Rocket Medical plc, and
Fertility Focus Ltd. These players are focused on launching advanced
technologies that are likely to substantially improve the outcome of the
IVF cycles. This will help them gain a competitive edge over others.
No comments:
Post a Comment